Essential thrombocythaemia

2 trials 1 recruiting MedDRA PT
2 Registered trials
1 Recruiting
2 Unique sponsors
1 Unique IMPs
2 Commercial trials
Drug classes (ATC)
— ATC code not specified 1
L Oncology (ATC L) 1
Mechanism of action (INN-stem analysis)
Interferon 1 substance
Phase III: 1 Phase I (Other): 1

Filter these 2 trials by country, sponsor, date range and more.

Open in Search → Gap analysis →
Show: 2 trials

Phase III

1 trial
  • Aop Orphan Pharmaceuticals GmbH Commercial
    ROPEGINTERFERON ALFA-2B
    2023-505160-12-00 10 countries 2023 n=132 Orphan
    Ended

Phase I (Other)

1 trial
  • Step Pharma Commercial
    IMP not specified
    2024-519964-42-00 1 country 2025 n=13
    Recruiting
Sponsor activity
SponsorTypeTrialsPhasesRecruiting
Step Pharma Commercial 1 Phase I (Other) 1
Aop Orphan Pharmaceuticals GmbH Commercial 1 Phase III 0
New trials by year
2023
1
2025
1
← All indication landscapes